tradingkey.logo
tradingkey.logo
Pesquisar

Qiagen NV

QGEN
Adicionar à lista de desejos
43.800USD
+0.110+0.25%
Horário de mercado 09/23, 09:39ET
9.03BValor de mercado
23.44P/L TTM

Sobre o Qiagen NV Empresa

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Qiagen NV Perfil

Código da empresaQGEN
Nome da EmpresaQiagen NV
Data de listagemSep 01, 1996
CEOBernard (Thierry)
Número de funcionários5765
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 01
EndereçoHulsterweg 82
CidadeVENLO
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísNetherlands
Código postal5912 PL
Telefone31773556600
Sitehttps://www.qiagen.com/
Código da empresaQGEN
Data de listagemSep 01, 1996
CEOBernard (Thierry)

Executivos da empresa Qiagen NV

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
349.19K
-4.22%
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
349.19K
-4.22%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
167.23K
+2.41%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
167.23K
+2.41%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
49.12K
+8.67%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
49.12K
+8.67%
Prof. Dr. Ross L. Levine, M.D.
Prof. Dr. Ross L. Levine, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
15.46K
+23.57%
Prof. Dr. Elaine R. Mardis, Ph.D.
Prof. Dr. Elaine R. Mardis, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
3.77K
--
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
22.00
-4.55%
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Chairman of the Supervisory Board
Independent Chairman of the Supervisory Board
22.00
-4.55%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
349.19K
-4.22%
Mr. Roland Sackers
Mr. Roland Sackers
Managing Director, Chief Financial Officer, Member of the Executive Board
Managing Director, Chief Financial Officer, Member of the Executive Board
349.19K
-4.22%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
167.23K
+2.41%
Dr. Metin Colpan, Ph.D.
Dr. Metin Colpan, Ph.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
167.23K
+2.41%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
49.12K
+8.67%
Tallett (Elizabeth E)
Tallett (Elizabeth E)
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
49.12K
+8.67%

Perguntas frequentes

Quem são os cinco principais acionistas de Qiagen NV?

Os cinco principais acionistas de Qiagen NV são: Mr. Roland Sackers

Quantas instituições possuem ações da Qiagen NV (QGEN)?

Em 2026Q1, 1005 instituições possuíam ações da Qiagen NV, com valor de mercado aproximado de 161.40M, representando 78.32% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -30070961.00.

Qual é a maior fonte de receita da Qiagen NV?

Em 2026Q1, o segmento de negócios Consumables and Related Revenues gerou a maior receita para Qiagen NV, totalizando 483.53M e representando 90.37% da receita total.
tradingkey.logo
Aviso de risco: Nosso site e aplicativo móvel fornecem apenas informações gerais sobre determinados produtos de investimento. A Finsights não oferece, e o fornecimento de tais informações não deve ser interpretado como se a Finsights estivesse oferecendo, aconselhamento financeiro ou recomendação para qualquer produto de investimento.
Os produtos de investimento estão sujeitos a riscos significativos, incluindo a possível perda do valor investido e podem não ser adequados para todos. O desempenho passado dos produtos de investimento não é indicativo de seu desempenho futuro.
A Finsights pode permitir que anunciantes ou afiliados realizem, ou forneçam anúncios em nosso site, ou aplicativo móvel, ou em qualquer parte deles e pode ser compensada por eles com base em sua interação com os anúncios.
 © Copyright: FINSIGHTS MEDIA PTE. LTD. Todos os direitos reservados.